Infographic

How Pharma Companies Can Gain an Edge with M&A

As dealmaking becomes more competitive and expensive, the margin for error is shrinking. Companies need to double down on M&A fundamentals.

By Kai Grass, Sarwar Islam, Floriane Haas-Falanga, and Andy Pasternak

Why there’s more pressure to make deals that create value.

First published in julio 2024

Speak to our experts in Please select an industry from the dropdown list

We help global leaders with their organization's most critical issues and opportunities. Together, we create enduring change and results

Your work email address Please enter a valid email address